In Vitro Diagnostics (IVD) in Malaysia, Singapore and Indonesia, 2022

The Asia Pacific (APAC) region is a fast-growing in vitro diagnostics (IVD) market, which is witnessing increasing focus by leading global players in the market. Southeast Asia has been identified as one of the key regions in APAC region offering significant opportunities for IVD companies.

This report focuses on three IVD markets in Southeast Asia: Malaysia, Indonesia, and Singapore. These three countries together represent a fast-growing geographic region offering significant opportunity for IVD companies. The total population of these three countries is over 310 million, which is close to the population in the United States.

Among these three countries, Singapore has established world class healthcare service capabilities in terms of infrastructure as well as skilled manpower. Though the population is less than 6 million, the Singapore market is attractive for IVD companies and it has become a medical tourism hub in the region. Indonesia, on the other hand, is a country with a huge population of about 275 million people. The country is taking significant steps to improve its healthcare infrastructure, which is offering considerable opportunities for IVD companies. The Malaysian market, with a population of about 32 million falls in between these two countries, both in terms of healthcare service capabilities and growth potentials.

In Vitro Diagnostics (IVD) in Malaysia, Singapore, and Indonesia, 2022 covers the following segments:

POC
Clinical Chemistry
Immunoassays
Molecular Assays
Hematology
Coagulation
Microbiology and Virology
Blood Testing and Typing
Histology and Cytology

The report also profiles key companies in the market:

Abbott Diagnostics
ARKRAY
Beckman Coulter, Inc. / Danaher
Becton, Dickinson, and Company (BD)
BioCytech Corporation
bioMérieux Inc.
Bio-Rad Laboratories, Inc.
Caris Life Sciences
Cephei
CTK Biotech Inc
Danaher Corporation
Dexcom
DiaSorin S.p.A
Grifols S.A.
Healgen Scientific LLC
Hologic, Inc.
Horiba Medical
Lucence Diagnostics
Medical Innovation Ventures Sdn. Bhd. (Mediven)
Mindray (Shenzhen Mindray Bio-medical Electronics Co., Ltd.)
MiRXES Pte Ltd.
OraSure Technologies, Inc.
Ortho Clinical Diagnostics (Ortho)
PerkinElmer, Inc. (PE)
QIAGEN
Reszon Diagnostics International
Roche Diagnostics
Sysmex Corporation
Vela Diagnostics
Veredus Laboratories Pte Ltd

Chapter 1: Executive Summary

Malaysia: Healthcare and Regulatory Landscape
Regulation of Medical devices in Malaysia
IVD Market Size Estimation and Forecast for Malaysia
Table 1-1: Malaysia’s IVD Market, by Segment (POC, Clinical Chemistry, Immunoassays, Molecular Assays, Hematology, Coagulation, Microbiology and Virology, Blood Testing and Typing, & Histology and Cytology), 2022-2027 ($ Millions)
Indonesia: Healthcare and Regulatory Landscape
Market Drivers and Challenges
The Health Insurance System
Table 1-2: Indonesia’s Medical Device Demand, Local Production, Exports, and Imports, 2018-2021, ($ Billions)
Policies on Procurement, Import, Market Authorization, and Halal Certification of IVDs
IVD Market Size Estimation and Forecast for Indonesia
Table 1-3: Indonesia’s IVD Market, by Segment (POC, Clinical Chemistry, Immunoassays, Molecular Assays, Hematology, Coagulation, Microbiology and Virology, Blood Testing and Typing, & Histology and Cytology), 2022-2027 ($ Millions)
Singapore: Healthcare and Regulatory Landscape
The Health Insurance System
Policies on Import, Registration, and Distribution of IVDs in Singapore
Recovery of the Medical Tourism Sector
IVD Market Size Estimation and Forecast for Singapore
Table 1-4: Indonesia’s IVD Market, by Segment (POC, Clinical Chemistry, Immunoassays, Molecular Assays, Hematology, Coagulation, Microbiology and Virology, Blood Testing and Typing, & Histology and Cytology), 2022-2027 ($ Millions)
The Combined IVD Markets of Malaysia, Indonesia, and Singapore
Table 1-5: Total IVD Market Size in Malaysia, Indonesia, and Singapore and Forecasts, 2022-2027 ($ Millions)
Table 1-6: Market Shares of the Leading IVD Companies (Roche, Abbott, Siemens Healthineers, Beckman Coulter, bioMérieux, Bio-Rad, Sysmex, and Others) in Malaysia, Indonesia, and Singapore, 2022

Chapter 2: COVID-19 Testing Market Trends

COVID-19 Testing Trends in Malaysia (2020-2022)
Table 2-1: COVID-19 Self-Tests Approved in Malaysia (As of February 2022)
Table 2-2: Covid-19 Testing Markets (Molecular Assays, Immunoassays, and POC Tests) in Malaysia, 2022-2027 ($ Millions)
Table 2-3: COVID-19 Testing Types (Immunoassay Lab-based, Molecular Diagnostics Lab-based, and Rapid-POC) and their Shares in Malaysia, 2022, ($ Millions)
COVID-19 Testing Trends in Indonesia (2020-2022)
Table 2-4: Covid-19 Testing Markets (Molecular Assays, Immunoassays, and POC Tests) in Indonesia, 2022-2027 ($ Millions)
Table 2-5: COVID-19 Testing Market Segments (Immunoassay Lab-based, Molecular Diagnostics Lab-based, and Rapid-POC) and their Shares in Indonesia, 2022, ($ Millions)
COVID-19 Testing Trends in Singapore (2020-2022)
Table 2-6: Covid-19 Testing Markets (Molecular Assays, Immunoassays, and POC Tests) in Singapore, 2022-2027 ($ Millions)
Table 2-7: COVID-19 Testing Market Segments (Immunoassay Lab-based, Molecular Diagnostics Lab-based, and Rapid-POC) and their Shares in Singapore, 2022 ($ Millions)
Table 2-8: COVID-19 Testing Market Segments (Immunoassay Lab-based, Molecular Diagnostics Lab-based, and Rapid-POC) and their Combined Shares in Malaysia, Indonesia, and Singapore, 2022 ($ Millions)
Table 2-9: COVID-19 Testing Markets in Malaysia, Indonesia, and Singapore, 2022-2027 ($ Millions)

Chapter 3: Point-of-Care Tests

Pregnancy and Fertility Testing
Cancer Testing
Lipid Testing
Drug of Abuse (DOA) Testing
Infectious Disease Testing
HIV
Hepatitis
Table 3-1: Prevalence of Co-infection of HIV with HBV and HCV in Malaysia, Indonesia, and Singapore
Tuberculosis (TB)
Tropical Diseases
Dengue
Filariasis
Leptospirosis
Malaria
Typhoid
Table 3-2: Selected List of Companies Offering POC Tests for Tropical Diseases in Malaysia, Indonesia, and Singapore
Respiratory Diseases
Sexual Health
Diabetes Testing - Blood Glucose Monitoring
Other POC tests
Table 3-3: POC Test Sales by Category (Fertility/ Pregnancy, Covid-19, Other Infectious diseases, Glucose (self), Glucose Continuous, Glucose Professional, HbA1c POC, Fecal Occult Blood Critical care POC, Coagulation, Cardiac Markers, Hematology, Drug of Abuse, Cholesterol, and Other), Malaysia, 2022-2027 ($ Millions)
Table 3-4: POC Test Sales by Category (Fertility/ Pregnancy, Covid-19, Other Infectious diseases, Glucose (self), Glucose Continuous, Glucose Professional, HbA1c POC, Fecal Occult Blood Critical care POC, Coagulation, Cardiac Markers, Hematology, Drug of Abuse, Cholesterol, and Other), Indonesia, 2022-2027 ($ Millions)
Table 3-5: POC Test Sales by Category (Fertility/ Pregnancy, Covid-19, Other Infectious diseases, Glucose (self), Glucose Continuous, Glucose Professional, HbA1c POC, Fecal Occult Blood Critical care POC, Coagulation, Cardiac Markers, Hematology, Drug of Abuse, Cholesterol, and Other), Singapore, 2022-2027 ($ Millions)
Table 3-6: POC Test Sales in Malaysia, Indonesia, and Singapore, 2022-2027 ($ Millions)
Table 3-7: Estimation of Market Shares of the Leading Companies (Abbott, Roche, and Siemens Healthineers) in the POC Testing Markets in Malaysia, Indonesia, and Singapore, 2022

Chapter 4: Core Lab and Clinical Chemistry

Workstation Consolidation and Laboratory Automation
Core Lab: Market Analysis
Table 4-1: Core Lab Automation Solutions Used by a Selected List of Hospitals (MOH Hospitals [General Hospitals], MOH [District Hospitals], University Hospitals, and Private Hospitals) in Malaysia
Table 4-2: Core Lab Solution Sales in Malaysia, Indonesia, and Singapore; 2022-2027 ($ Millions)
Table 4-3: Leading Companies (Roche, Abbott, Siemens, Healthineers, Beckman Coulter, and Other) in the Core Lab Solutions Markets in Malaysia, Indonesia, and Singapore, 2022
Clinical Chemistry Market Analysis
Blood Gases and Electrolytes
Urinalysis
Table 4-4: Clinical Chemistry Sales by Test Category (General Chemistry, Blood Gases, and Urinalysis), Malaysia, 2022-2027 ($ Millions)
Table 4-5: Clinical Chemistry Sales by Test Category (General Chemistry, Blood Gases, and Urinalysis), Indonesia, 2022-2027 ($ Millions)
Table 4-6: Clinical Chemistry Sales by Test Category (General Chemistry, Blood Gases, and Urinalysis), Singapore, 2022-2027 ($ Millions)

Chapter 5: Immunoassays

Cardiac Markers
Tumor Markers
Diabetes
Thyroid
Autoimmune Diseases
Other Immunoassay Segments
Table 5-1: Immunoassay (Non-Infectious Diseases) Sales by Category (Diabetes, Tumor Markers, Thyroid, Proteins, Cardiac Markers, and Other), Malaysia, 2022-2027 ($ Millions)
Table 5-2: Immunoassay (Non-Infectious Diseases) Sales by Category (Diabetes, Tumor Markers, Thyroid, Proteins, Cardiac Markers, and Other), Indonesia, 2022-2027 ($ Millions)
Table 5-3: Immunoassay (Non-Infectious Diseases) Sales by Category (Diabetes, Tumor Markers, Thyroid, Proteins, Cardiac Markers, and Other), Singapore, 2022-2027 ($ Millions)
Table 5-4: Immunoassay (Non-Infectious Diseases) Sales in Malaysia, Indonesia, and Singapore; 2022-2027 ($ Millions)
Table 5-5: Leading Companies (Roche, Abbott, Siemens Healthineers, and Others) in the Immunoassays (Non-Infectious Diseases) Markets in Malaysia, Indonesia, and Singapore, 2022

Chapter 6: Molecular Assays

Oncology
Table 6-1: Selected List of NGS-based Cancer Tests Approved for Clinical Use in Singapore
Table 6-2: NGS-based Cancer Testing in Singapore: Key Challenges
Genetic Diseases and Disorders
Prenatal Testing, Pre-Implantation Genetic Testing, etc.
Transplant Diagnostics
Table 6-3: Molecular Diagnostics (Non-Infectious Diseases) Sales* by Category (Oncology Assays, Genetic Diseases, and Transplant Testing), Malaysia, 2022-2027 ($ Millions)
Table 6-4: Molecular Diagnostics (Non-Infectious Diseases) Sales* by Category (Oncology Assays, Genetic Diseases, and Transplant Testing), Indonesia, 2022-2027 ($ Millions)
Table 6-5: Molecular Diagnostics (Non-Infectious Diseases) Sales* by Category (Oncology Assays, Genetic Diseases, and Transplant Testing), Singapore, 2022-2027 ($ Millions)
Table 6-6: Molecular Diagnostics (Non-Infectious Diseases) Sales* in Malaysia, Indonesia, and Singapore; 2022-2027 ($ Millions)
Table 6-7: Leading Companies (Roche, Abbott, QIAGEN, and Others) in the Molecular Diagnostics (Non-Infectious Diseases) Markets in Malaysia, Indonesia, and Singapore, 2022

Chapter 7: Hematology

Laboratory-based Hematology: Technology and Market Trends
Table 7-1: Laboratory-based Hematology Sales in Malaysia, Indonesia, and Singapore; 2022-2027 ($ Millions)
Table 7-2: Leading Companies (Sysmex, Beckman Coulter/Danaher, Mindray, Roche, and Others) in the Laboratory-based Hematology Markets in Malaysia, Indonesia, and Singapore, 2022

Chapter 8: Coagulation

Impact of COVID-19
Lab-based Coagulation Testing
Table 8-1: Lab-based Coagulation Test Sales, Malaysia, 2022-2027 ($ Millions)
Table 8-2: Lab-based Coagulation Test Sales, Indonesia, 2022-2027 ($ Millions)
Table 8-3: Lab-based Coagulation Test Sales, Singapore, 2022-2027 ($ Millions)
Table 8-4: Lab-based Coagulation Test Sales in Malaysia, Indonesia, and Singapore, 2022-2027 ($ Millions)
Table 8-5: Estimation of Market Shares of the Leading Companies in the Lab-based Coagulation Testing Markets in Malaysia, Indonesia, and Singapore, 2022

Chapter 9: Microbiology and Virology

Antibiotic Resistant Infections: Challenges and Solutions
Syndromic Testing
Diagnosis of Prevalent Infectious Diseases in Malaysia, Indonesia, and Singapore
Hepatitis Testing
Table 9-1: Selected List of Commercial Clinical Microbiology Immunoassays and Molecular Assays for Hepatitis in Malaysia, Indonesia, and Singapore
Sepsis and Hospital Acquired Infections (HAI) Testing
HIV Testing
Table 9-2: Selected List of Commercial Clinical Microbiology Immunoassays and Molecular Assays for HIV in Malaysia, Indonesia, and Singapore
Sexually Transmitted Diseases (STDs) Testing
Table 9-3: Selected List of Commercial Clinical Microbiology Immunoassays and Molecular Assays for STDs* in Malaysia, Indonesia, and Singapore
ToRCH
Respiratory Infection Testing
Clinical Microbiology and Virology Market Segments
Tuberculosis (TB) Testing
Other Prevalent Infectious Diseases and their Diagnosis in Malaysia, Indonesia, and Singapore
ID/AST: Market Analysis
ID/AST Systems: Panels, Auto, and Supplies
Table 9-4: ID/AST Systems Market Distribution by Product Type (Panels, Supplies, and Auto) in Malaysia, Indonesia, and Singapore
Blood Culture
Chromogenic Media
Rapid Tests Performed on Colonies from Culture Media
Table 9-5: Microbiology ID/AST Markets in Malaysia, 2022-2027 ($ Millions)
Table 9-6: Microbiology ID/AST Markets in Indonesia, 2022-2027 ($ Millions)
Table 9-7: Microbiology ID/AST Markets in Singapore, 2022-2027 ($ Millions)
Table 9-8: ID/AST Markets in Malaysia, Indonesia, and Singapore, 2022-2027 ($ Millions)
Microbiology Immunoassays
Table 9-9: Laboratory-based Microbiology Immunoassays Markets in Malaysia, 2022-2027 ($ Millions)
Table 9-10: Market Shares of the Leading Companies in the Lab-based Microbiology Immunoassay Markets in Malaysia, 2022
Table 9-11: Laboratory-based Microbiology Immunoassays Markets in Indonesia, 2022-2027 ($ Millions)
Table 9-12: Market Shares of the Leading Companies in the Lab-based Microbiology Immunoassay Markets in Indonesia, 2022
Table 9-13: Laboratory-based Microbiology Immunoassays Markets in Singapore, 2022-2027 ($ Millions)
Table 9-14: Market Shares of the Leading Companies in the Lab-based Microbiology Immunoassay Markets in Singapore, 2022
Table 9-15: Combined Clinical Laboratory-Based Microbiology Immunoassay Market by Pathogen in Malaysia, Indonesia, and Singapore, 2022 ($ millions)
Table 9-16: Microbiology Immunoassays (Lab-based) Markets in Malaysia, Indonesia, and Singapore, 2022-2027 ($ Millions)
Molecular Microbiology (Laboratory-based)
Table 9-17: Laboratory-based Molecular Microbiology Markets in Malaysia, 2022-2027 ($ Millions)
Table 9-18: Laboratory-based Molecular Microbiology Markets in Indonesia, 2022-2027 ($ Millions)
Table 9-19: Laboratory-based Molecular Microbiology Markets in Singapore, 2022-2027 ($ Millions)
Table 9-20: Combined Clinical Molecular Microbiology Market by Pathogen in Malaysia, Indonesia, and Singapore, 2022 ($ millions)
Table 9-21: Microbiology Mole
Table 9-22: Microbiology ancular Diagnostics Markets in Malaysia, Indonesia, and Singapore, 2022-2027 ($ Millions)d Virology Markets in Malaysia, Indonesia, and Singapore, 2022-2027 ($ Millions)

Chapter 10: Blood Banking Services

Blood Typing and Grouping
Blood Testing
Market Trends Triggered by COVID-19 Pandemic
Blood Banking Service Markets in Malaysia
Table 10-1: Blood Testing and Typing Market by Category, Malaysia, 2022-2027 ($ Millions)
Table 10-2: Market Shares of the Leading Companies in the Blood Testing and Typing Markets in Malaysia, 2022
Blood Banking Service Markets in Indonesia
Table 10-3: Distribution of Blood Centers (BCs) in Indonesia, by Province
Table 10-4: Blood Testing and Typing Market by Category, Indonesia, 2022-2027 ($ Millions)
Table 10-5: Market Shares of the Leading Companies in the Blood Testing and Typing Markets in Indonesia, 2022
Blood Banking Service Markets in Singapore
Table 10-6: Blood Testing and Typing Market by Category, Singapore, 2022-2027 ($ Millions)
Table 10-7: Blood Testing and Typing Markets in Malaysia, Indonesia, and Singapore, 2022-2027 ($ Millions)

Chapter 11: Histology and Cytology

HPV Testing: A Fast-Growing Market Segment
Technological Advancements in Histology and Cytology
Market Trends
Table 11-1: Cervical Cancer Incidences in Singapore, Malaysia, and Indonesia, 2020
Table 11-2: Cervical Cancer Deaths in Singapore, Malaysia, and Indonesia, 2020
Table 11-3: Leading Vendors Offering Cervical Cancer Screening Products in Malaysia, Indonesia, and Singapore
Histology and Cytology Markets in Malaysia
Digital Pathology Solutions in Malaysia
Table 11-4: The Histology and Cytology IVD Markets in Malaysia, by Type: 2022 -2027
Histology and Cytology Markets in Indonesia
Digital Pathology Solutions in Indonesia
Table 11-5: The Histology and Cytology IVD Markets in Indonesia, by Type: 2022 -2027
Histology and Cytology Markets in Singapore
Digitization of Histology Laboratories in Singapore
Table: 11-6: The Histology and Cytology IVD Markets in Singapore, by Type: 2022 - 2027
Table 11-7: Histology and Cytology Markets in Malaysia, Indonesia, and Singapore, 2022-2027 ($ Millions)
Table 11-8: Market Shares of the Leading Companies in the Histology and Cytology Markets in Malaysia, Indonesia, and Singapore, 2022

Chapter 12: Company Profiles

The Top Tier IVD Companies in Malaysia, Indonesia, and Singapore
Abbott Diagnostics
Beckman Coulter, Inc./Danaher
Clinical Chemistry
Immunoassays
Hematology
Microbiology and Blood Banking
Core Lab Systems
Flow Cytometry
COVID-19
Becton, Dickinson, and Company (BD)
Cytology
Molecular Microbiology
Traditional Microbiology and ID/AST
Blood Collection
Flow Cytometry
COVID-19
bioMérieux Inc.
Molecular Biology
Microbiology
Immunoassays
Blood Culture
Mass Spectrometry
COVID-19
Bio-Rad Laboratories, Inc.
Quality Control
Blood Bank
Diabetes
Immunoassays
Liquid Biopsy and Droplet Digital PCR
COVID-19
Cepheid/Danaher
COVID-19
Danaher Corporation
DiaSorin S.p.A
COVID-19
Grifols S.A.
Hologic, Inc.
Ortho Clinical Diagnostics (Ortho)
Blood Bank
Core Lab/Immunoassays
COVID-19
PerkinElmer, Inc. (PE)
COVID-19
QIAGEN
Prenatal Testing
Cervical Cancer
Transplant Medicine
COVID-19
Roche Diagnostics
Hematology
Immunoassays
HIV
Core Molecular
Diabetes Care
Coagulation
POC
HPV
Blood Bank
Transplant Medicine
Cancer Companion Testing
Prenatal
COVID-19
Siemens Healthineers
Core Lab
Lab Automation
Immunoassays
Hematology
Molecular
COVID-19
Sysmex Corporation
Hematology
Coagulation
Urinalysis
Immunoassays
Flow Cytometry
COVID-19
Company Profiles: The Second Tier - Multinationals, Regional Companies, etc.
ARKRAY
Dry Chemistry/Immunoassays
Urinalysis
Diabetes
Molecular
BioCytech Corporation
Caris Life Sciences
CTK Biotech Inc
Dexcom
New Manufacturing Facility in Malaysia
Healgen Scientific LLC
Horiba Medical
Lucence Diagnostics
Medical Innovation Ventures Sdn. Bhd. (Mediven)
Mindray (Shenzhen Mindray Bio-medical Electronics Co., Ltd.)
MiRXES Pte Ltd.
OraSure Technologies, Inc.
COVID-19
Reszon Diagnostics International
Vela Diagnostics
COVID-19
Veredus Laboratories Pte Ltd
COVID-19
IVD Distributors in Malaysia, Indonesia, and Singapore
Table 12-1: Selected List of IVD Distributors in Malaysia
Table 12-2: Selected List of IVD Distributors in Indonesia
Table 12-3: Selected List of IVD Distributors in Singapore

Companies Mentioned

Abbott Diagnostics
ARKRAY
Beckman Coulter, Inc. / Danaher
Becton, Dickinson, and Company (BD)
BioCytech Corporation
bioMérieux Inc.
Bio-Rad Laboratories, Inc.
Caris Life Sciences
Cephei
CTK Biotech Inc
Danaher Corporation
Dexcom
DiaSorin S.p.A
Grifols S.A.
Healgen Scientific LLC
Hologic, Inc.
Horiba Medical
Lucence Diagnostics
Medical Innovation Ventures Sdn. Bhd. (Mediven)
Mindray (Shenzhen Mindray Bio-medical Electronics Co., Ltd.)
MiRXES Pte Ltd.
OraSure Technologies, Inc.
Ortho Clinical Diagnostics (Ortho)
PerkinElmer, Inc. (PE)
QIAGEN
Reszon Diagnostics International
Roche Diagnostics
Sysmex Corporation
Vela Diagnostics
Veredus Laboratories Pte Ltd

License	Format	Properties	Price
SINGLE USER LICENSE Online Access - Lifetime	The product can be accessed through a secure website. Username and password will be sent via email. The access never expires.	This is a single user license, allowing one user access to the product.	€4885EUR$5,000USD£4,078GBP
1 - 10 USER LICENSE PDF	The product is a PDF.	This is a 1-10 user license, allowing up to ten users have access to the product.	€7328EUR$7,500USD£6,118GBP
ENTERPRISE LICENSE PDF	The product is a PDF.	This is an enterprise license, allowing all employees within your organization access to the product.	€9771EUR$10,000USD£8,157GBP

In Vitro Diagnostics (IVD) in Malaysia, Singapore, and Indonesia, 2022 covers the following segments:

The report also profiles key companies in the market:

Table of Contents

Companies Mentioned

Related Topics

Related Reports

In Vitro Diagnostics Market, Industry Trends and Global Forecasts to 2035: Distribution by Test Type, Type of Offering, Type of Technology, Therapeutic Area, End Users and Geographical Regions

Asia Pacific In Vitro Diagnostics - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts 2019 - 2029

In-Vitro Diagnostics Market by Component, Technology, Specimen, Application, End User - Global Forecast 2025-2030

In Vitro Diagnostic (IVD) Trends and Market Update: March 2024

The IVD Market in South Korea, 2024